441
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Gelucire-stabilized nanoparticles as a potential DNA delivery system

, &
Pages 647-654 | Received 31 Jan 2015, Accepted 08 Apr 2015, Published online: 27 Apr 2015

References

  • He SN, Li YL, Yan JJ, et al. Ternary nanoparticles composed of cationic solid lipid nanoparticles, protamine, and DNA for gene delivery. Int J Nanomedicine 2013;8:2859–2869
  • Kassim SH, Li H, Vandenberghe LH, et al. Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis. PLoS One 2010;5:e13424
  • Wagner AM, Schoeberlein A, Surbek D. Fetal gene therapy: opportunities and risks. Adv Drug Deliv Rev 2009;61:813–821
  • Cui Z, Mumper RJ. Plasmid DNA-entrapped nanoparticles engineered from microemulsion precursors: in vitro and in vivo evaluation. Bioconjug Chem 2002;13:1319–1327
  • Cortesi R, Campioni M, Ravani L, et al. Cationic lipid nanosystems as carriers for nucleic acids. N Biotechnol 2014;31:44–54
  • Wong FM, Reimer DL, Bally MB. Cationic lipid binding to DNA: characterization of complex formation. Biochemistry 1996;35:5756–5763
  • Goyal R, Tripathi SK, Tyagi S, et al. Gellan gum blended PEI nanocomposites as gene delivery agents: evidences from in vitro and in vivo studies. Eur J Pharm Biopharm 2011;79:3–14
  • Wehrung D, Geldenhuys WJ, Oyewumi MO. Effects of gelucire content on stability, macrophage interaction and blood circulation of nanoparticles engineered from nanoemulsions. Colloids Surfaces B Biointerfaces 2012;94:259–265
  • Wehrung D, Sun S, Chamsaz EA, et al. Biocompatibility and in vivo tolerability of a new class of photoresponsive alkoxylphenacyl-based polycarbonates. J Pharm Sci 2013;102:1650–1660
  • Wehrung D, Geldenhuys WJ, Bi L, Oyewumi MO. Biocompatibility, efficacy and biodistribution of gelucire-stabilized nanoparticles engineered for docetaxel delivery. J Nanosci Nanotechnol 2012;12:2901–2911
  • Oyewumi MO, Yokel RA, Jay M, et al. Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice. J Control Release 2004;95:613–626
  • Vonarbourg A, Passirani C, Saulnier P, Benoit JP. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials 2006;27:4356–4373
  • Sachs-Barrable K, Thamboo A, Lee SD, Wasan KM. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells. J Pharm Pharm Sci 2007;10:319–331
  • Traunecker HC, Stevens MC, Kerr DJ, Ferry DR. The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells. Br J Cancer 1999;81:942–951
  • Wehrung D, Bi L, Geldenhuys WJ, Oyewumi MO. Antitumor efficacy and tolerability of systemically administered gallium acetylacetonate-loaded gelucire-stabilized nanoparticles. J Biomed Nanotechnol 2013;9:1029–1040
  • Li X, Nie SF, Kong J, et al. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int J Pharm 2008;363:177–182
  • Date AA, Vador N, Jagtap A, Nagarsenker MS. Lipid nanocarriers (GeluPearl) containing amphiphilic lipid Gelucire 50/13 as a novel stabilizer: fabrication, characterization and evaluation for oral drug delivery. Nanotechnology 2011;22:275102
  • Noriega-Pelaez EK, Mendoza-Munoz N, Ganem-Quintanar A, Quintanar-Guerrero D. Optimization of the emulsification and solvent displacement method for the preparation of solid lipid nanoparticles. Drug Dev Ind Pharm 2011;37:160–166
  • Shimpi S, Chauhan B, Mahadik KR, Paradkar A. Preparation and evaluation of diltiazem hydrochloride-Gelucire 43/01 floating granules prepared by melt granulation. AAPS PharmSciTech 2004;5:e43
  • Cui Z, Qiu F, Sloat BR. Lecithin-based cationic nanoparticles as a potential DNA delivery system. Int J Pharm 2006;313:206–213
  • Koping-Hoggard M, Varum KM, Issa M, et al. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther 2004;11:1441–1452
  • Tiyaboonchai W, Woiszwillo J, Middaugh CR. Formulation and characterization of DNA–polyethylenimine–dextran sulfate nanoparticles. Eur J Pharm Sci 2003;19:191–202
  • Munier S, Messai I, Delair T, et al. Cationic PLA nanoparticles for DNA delivery: comparison of three surface polycations for DNA binding, protection and transfection properties. Colloids Surf B Biointerfaces 2005;43:163–173
  • Iles KE, Forman HJ. Macrophage signaling and respiratory burst. Immunol Res 2002;26:95–105
  • Kuo JH, Lin YL, Tseng JW. Interactions between U-937 human macrophages and tyloxapol. Colloids Surf B Biointerfaces 2008;64:208–215

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.